OCSL Stock Price & Analysis

Oaktree Specialty Lending Corp

OCSL

Oaktree Specialty Lending Corp

15.320

+15.320(+0%)6M

OCSL Stock Price Chart

YTD

OCSL Key Stats

High

15.410

Vol

648.65K

Low

15.265

Amount

9.95M

Open

15.320

VWAP

15.34

Mkt Cap

1.26B

EV/EBITDA(TTM)

15.01

OCSL Company Profile

Oaktree Specialty Lending Corporation is a specialty finance company. The Company provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Its portfolio of investments includes application software, multi-sector holdings, data processing and outsourced services, pharmaceuticals, biotechnology, health care services, specialized finance, personal products, and more. The Company is externally managed by Oaktree Fund Advisors, LLC (Oaktree).

OCSL Technical Analysis

Instant technical analysis with one click on any asset

OCSL Why It Moves

Find out the reasons behind the current stock movement

Should I Buy OCSL

AI-powered analysis to guide your buy, sell, or hold decision for this stock

OCSL News Sentiment

AI uncovers potential trading opportunities based on news sentiment

OCSL Technical Analysis

Instant technical analysis with one click on any asset

OCSL Why It Moves

Find out the reasons behind the current stock movement

Should I Buy OCSL

AI-powered analysis to guide your buy, sell, or hold decision for this stock

OCSL News Sentiment

AI uncovers potential trading opportunities based on news sentiment

OCSL Fundamental Analysis

buy

Moderate Buy

Buy

Hold

Sell

High

18.00

Averages

16.50

Low

15.00

Analyst

Rating

Action

Price Target

Date

Rating Reason

Oppenheimer

Mitchel Penn

Hold

Maintains

$18

2024-11-22

JP Morgan

Melissa Wedel

Buy

→

Hold

Downgrades

$17 → $15

2024-11-20

JPMorgan

B. Riley Securities

Bryce Rowe

Hold

Maintains

$17 → $15

2024-11-20

Keefe, Bruyette & Woods

Paul Johnson

Hold

Maintains

$18 → $17

2024-11-20

Keefe

JMP Securities

Brian McKenna

Buy

→

Hold

Downgrades

n/a

2024-11-19

JMP

Analyst	Rating	Action	Price Target	Date	Rating Reason

Oppenheimer Mitchel Penn	Hold	Maintains	$18	2024-11-22
JP Morgan Melissa Wedel	Buy → Hold	Downgrades	$17 → $15	2024-11-20	JPMorgan
B. Riley Securities Bryce Rowe	Hold	Maintains	$17 → $15	2024-11-20
Keefe, Bruyette & Woods Paul Johnson	Hold	Maintains	$18 → $17	2024-11-20	Keefe
JMP Securities Brian McKenna	Buy → Hold	Downgrades	n/a	2024-11-19	JMP

OCSL Earnings Analysis

Oaktree Specialty Lending Corp Corporation (OCSL.O) Q1 2025 Earnings Conference Call

Positive

Earnings Performance Exceeds Expectations: Oaktree Specialty Lending Corporation reported an EPS of $0.545, exceeding expectations of $0.54, demonstrating strong earnings performance.
Stock Issuance Impact: The company raised $100 million through the issuance of common stock at a price of $17.63 per share, resulting in a nearly 7% increase to NAV.
Dividend Declaration Announcement: A base dividend of $0.40 per share and a supplemental dividend of $0.07 per share were declared, reflecting a commitment to returning capital to shareholders.
Diversified Investment Portfolio: The portfolio remains well diversified with $2.8 billion invested across 136 companies, and the weighted average yield on debt investments is a healthy 10.7%.
Portfolio Performance Improvement: Paydowns, exits, and sales in the first quarter generated $352 million, up from $338 million in the previous quarter, indicating strong portfolio performance.

Negative

Adjusted NII Decline: Adjusted NII decreased to $0.54 per share, down from $0.55 per share in the prior quarter, indicating a slight decline in profitability.
Net Asset Value Decline: Net asset value per share fell to $17.63 from $18.09 last quarter, reflecting a decrease in the company's overall value.
Investment Income Decline: Adjusted total investment income declined by $8 million compared to the prior quarter, primarily due to lower non-recurring revenue and interest income.
Non-Accrual Investment Concerns: 3.9% of the portfolio at fair value and 5.1% at cost were classified as non-accrual investments, indicating ongoing credit quality issues.
Incentive Fee Waiver: The company waived $6.2 million in Part I incentive fees this quarter, highlighting challenges in generating sufficient returns to meet performance targets.

Positive

Earnings Performance Exceeds Expectations: Oaktree Specialty Lending Corporation reported an EPS of $0.545, exceeding expectations of $0.54, demonstrating strong earnings performance.
Stock Issuance Impact: The company raised $100 million through the issuance of common stock at a price of $17.63 per share, resulting in a nearly 7% increase to NAV.
Dividend Declaration Announcement: A base dividend of $0.40 per share and a supplemental dividend of $0.07 per share were declared, reflecting a commitment to returning capital to shareholders.
Diversified Investment Portfolio: The portfolio remains well diversified with $2.8 billion invested across 136 companies, and the weighted average yield on debt investments is a healthy 10.7%.
Portfolio Performance Improvement: Paydowns, exits, and sales in the first quarter generated $352 million, up from $338 million in the previous quarter, indicating strong portfolio performance.

Negative

Adjusted NII Decline: Adjusted NII decreased to $0.54 per share, down from $0.55 per share in the prior quarter, indicating a slight decline in profitability.
Net Asset Value Decline: Net asset value per share fell to $17.63 from $18.09 last quarter, reflecting a decrease in the company's overall value.
Investment Income Decline: Adjusted total investment income declined by $8 million compared to the prior quarter, primarily due to lower non-recurring revenue and interest income.
Non-Accrual Investment Concerns: 3.9% of the portfolio at fair value and 5.1% at cost were classified as non-accrual investments, indicating ongoing credit quality issues.
Incentive Fee Waiver: The company waived $6.2 million in Part I incentive fees this quarter, highlighting challenges in generating sufficient returns to meet performance targets.